Genetic alterations have been identified in neuroblastomas, including segmental chromosome 1p, 3p, 4p, and 11q deletions, and 1q and 17q gain; gene mutations including MYCN amplification, ALK amplification and mutation, and LIN28B amplification and polymorphism. This evidence concerns the gene MYCN and neuroblastoma.